Difference between revisions of "Part:BBa K4229072"

Revision as of 19:54, 10 October 2022

BMC-T1_T35TAG

Short Description:

The T35X variant of BMC-T1 was created using site-directed mutagenesis, aiming to insert a non-canonical amino acid at position 8 of the peptide sequence by amber stop codon. The BMC-T1_T35X can only be completely synthesized upon successful amber stop codon suppression. Hence, BMC-T1_T35X can be used to create a ncAA modified shell protein for the assembly of a synthetic carboxysome.

Usage:

Besides the well-known 20 canonical amino acids, there is a variety of non-canonical amino acids which can be used to further modify proteins. One way of incorporating non-canonical amino acids is via the amber stop codon suppression technology. This part BMC-T1_T35X, is a model protein to test non-canonical amino acid incorporation. Without successful incorporation, a non-functional version of BMC-T1 will be translated, and the synthetic carboxysome cannot form. However, after successful incorporation of the non-canonical amino acid, translation will go on as normal and the synthetic carboxysome can form.

Characterization:

The incorporation of non-canonical amino acids into BMC-T1_T35X was characterized using SDS-PAGE, Western blot, and antibody decoration. As an orthogonal translation system, an additional aminoacyl-tRNA synthetase and its corresponding tRNA are used, which in this case correspond to the pBpf synthetase, which incorporates 4-Benzoyl-l-phenylalanine.

Figure text: SDS-PAGE with whole cell lysis confirming the incorporation of pAzF at position 8, 35, 78 and 96 of the BMC-T1 protein. The cells grew until OD 0.4, following the addition of arabinose and a growth period of 2 h. After the 2 h the cells were treated with IPTG and grew 24 hours before harvesting by centrifugation. The BlueClassic Prestained Protein Marker, 10-180 kDa from Jena Bioscience was used as ladder. To purify the protein, the His-Spin Protein Miniprep from Zymo Research was used.

Sequence and Features